Silencing FLVCR1-AS1 inhibited cell proliferation and inhibition of miR-381-3p, which was identified as a potential target gene of FLVCR1-AS1, reversed the tumor-restraining impacts of FLVCR1-AS1 depletion on BC progression [41]. The gene discussed is FLVCR1; the disease is breast cancer.